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Summary 
Alloantigen-stimulated CD8 + mouse spleen cells, ei- 
ther spontaneously or in the presence of IL-12 or IFNy 
plus anti-IL-4, differentiate into CD8+ T cells secreting 
a Thl-like cytokine pattern (IL-2 and IFNT). IL-4 in- 
duced differentiation into CD8+ T cells secreting Th2 
cytokines (IL-4, IL-5, IL-8, and IL-lo), whereas anti- 
IFNy suppressed the development of CD8+ cellssecre- 
ting IFNy. Clones of IL-4- or IFfly-producing CD8+ T 
cells were relatively stable, as IL-4 or IFNy did not 
cause interconversion of committed CD8+ T cells. 
Both CD8+ subsets were cytotoxlc, failed to provide 
cognate help for B cell antlbody production, and re- 
mained CD4-, CDBa+CD88 + . We propose the names 
TCl and TC2 for cytotoxic CD8+ T cells secreting Thl- 
like and ThP-like cytokines, respectively. 
Introduction 
CD4+ T cells secreting different cytokine patterns contrib- 
ute to the regulation of different types of immunity. Two 
distinct patterns, T helper cell 1 (Thl), which secretes in- 
terleukin-2 (IL-2) interferon? (IFNy), and LT, and Th2, 
which secretes IL-4,lL-5, IL-6, IL-g, IL-lo, and IL-13, were 
originally identified among a panel of mouse Th clones 
(Mosmann et al., 1986; Cherwinski et al., 1987; Mosmann 
and Coffman, 1989). Thl -like and ThP-like patterns have 
also been identified among human Th clones (Del Prete 
et al., 1991; Wierenga et al., 1990; Haanen et al., 1991) 
and in vivo during several strong parasitic infections in 
mice (Heinzel et al., 1989; Scott et al., 1966; Else et al., 
1992; Sher et al., 1992). Other cytokine patterns have also 
been described, particularly the ThO pattern that includes 
both Thl and Th2 cytokines (Firestein et al., 1989; Street 
et al., 1990; Paliard et al., 1986). The different cytokines 
of Thl and Th2 cells lead to distinct functions, which are 
often cross-inhibitory (Mosmann and Coffman, 1989). Thl 
cells mediate delayed-type hypersensitivity (Cher and 
Mosmann, 1987), which is inhibited by the Th2 cytokines 
IL-4 and IL-10 (Powrie et al., 1993; Li et al., 1994). Th2 
cells are excellent helpers for 6 cell antibody synthesis, 
and enhance several aspects of allergic reactions(lsakson 
et al., 1962; Coff man and Carty, 1966; Sanderson et al., 
1986), whereas Thl cells synthesize IFNy, which inhibits 
some of these functions. 
Stimulated mouse CD8+ T cells usually secrete a Thl- 
like pattern of cytokines (Prystowsky et al., 1982; Fong 
and Mosmann, 1990). However, some human CD6+T cell 
clones secrete both IL-4 and IFNy (Paliard et al., 1988; 
Mingari et al., 1984). Furthermore, IL-4 and IFNy were 
produced by CD8+ T clones from leprosy patients with 
the lepromatous (high antibody levels) but not tuberculoid 
(strong delayed-type hypersensitivity) form of the disease 
(Salgame et al., 1991). These clones suppressed the pro- 
liferation of Mycobacterium leprae-specific CD4+ T cell 
clones. Cytotoxic CD8+ T cell clones producing IL4 but 
not IFNy were isolated from HIV-infected patients with 
Jobs-like syndrome (Maggi et al., 1994). In mice, IL4 stim- 
ulates CD8+ cells to secrete IL4 (Seder et al., 1992) and 
induces ionomycinlphorbol myristate acetate (PMA)-stim- 
ulated CD8+ T cells to differentiate into noncytolytic CD4- 
CD6- T cells that secrete ThP-like cytokines and provide 
anti-CD3-facilitated help for B cells (Erard et al., 1993). 
Thus, a number of investigators have demonstrated the 
existence of IL4-secreting nonCD4+ T cells, although 
some discrepancies were reported in CD6 expression and 
cytokine profiles. 
The differentiation of precursor CD4+ T cells into ef- 
fectors is influenced by several cytokines: IL-4 induces 
the differentiation of ThP-like cells (Le Gros et al., 1990; 
Swain et al., 1990), whereas IL-12, IFNy, and transforming 
growth factor 8 induce a Thl-like pattern (Hsieh et al., 
1993; Swain et al., 1991; Macatonia et al., 1993; Sad and 
Mosmann, 1994). Differentiation of CD6+ T cells into cyto- 
toxic effecters is enhanced by IL-1 (Farrar et al., 1960) 
IL-2 (Andrus et al., 1984) IL4 (Widmer and Grabstein, 
1987; Pfeifer et al., 1967), IFNy (Simon et al., 1986), and 
IL-12 (Mehrotra et al., 1993), but the precise mechanisms 
of several of these effects are not known. Although IL-4 
and ionomycin induced CD8+ T cells to lose CD8 expres- 
sion and cytotoxicity (Erard et al., 1993), in other studies 
IL-4 enhanced cytotoxicity in CD6+ T cell cultures stimu- 
lated with influenza virus, alloantigens, or mitogens 
(Widmer and Grabstein, 1967; Pfeiferet al., 1987; Horohov 
et al., 1988; Trenn et al., 1988). In many of these studies, 
the cytokine production profile of the resulting populations 
was not determined, and thus little is known about the 
cytokine costimulatory requirements for differentiation of 
CD6+ T cells into different subtypes. 
In this report, we show that IL-4, particularly in the ab- 
sence of IFNy, induces the differentiation of CD8+ T cells 
into effecters that secrete ThP-like cytokines IL-4, IL-5, 
IL-6, and IL-10 when restimulated. These allospecific Th2- 
like cells (TC2 cells) were CD8+, highly cytolytic, and pro- 
vided anti-CDS-facilitated, but not allospecific cognate 
help for B cell antibody production. 
Results 
IL-4 Induces Differentiation of CD8+ Precursors 
into ThS-Like CD8+ T Cells 
Enriched CD8’ spleen T cell populations were stimulated 
with irradiated allogeneic M 12.4.1 cells. Strong prolifera- 
tion resulted, and after 6 days the T cell blasts were 
washed and restimulated with concanavalin A (Con A). If 
primary cultures contained only IL-2, the CD8+ cells pro- 
immunity 
272 
$ Anti-IFH 
0 10 20 30 
IFMy @ml 
+==FG 
IL4 nglmi 
b io zil 
n IFNy nglmlrl0 
Cytokine secretion 
Figure 1, IL-4 Induces the Development of CD8+ T Ceils Secreting 
the Th2 Cytokine Pattern 
Purified C57BU6 CD8+ T ceilswere stimulated with aiiogeneic M12.4.1 
ceils (a), plate-bound anti-CD3 in the presence of syngeneic spleen 
ceils(b), or BALBlc spleen cells(c) under the various growth conditions 
indicated. After 6 days, the cells were washed and stimulated with 
Con A for 24 hr. Cytokine levels were measured in the supernatants. 
The means and standard deviations of triplicate cultures are shown. 
duced IFNy but no IL-4 or IL-5 when restimulated (Figure 
la). Similar results were obtained if the primary culture 
contained IFNy and anti-IL-4 (data not shown). Variable 
levels of IL-2 were produced by such cultures in different 
experiments. The presence of IL-4 plus anti-IFNy during 
the first 6 days of culture induced differentiation into CD6’ 
T cells that produced IL-4 and IL-5 whereas production 
of IFNy and IL-2 was reduced to low levels, normally below 
detectability (Figure la). Induction of the IL-4- and IL-5- 
secreting CD6+ T cells required a high dose of IL-4, while 
anti-IFNy prevented the differentiation of IFNy-secreting 
cells, particularly at low IL-4 concentrations (Figure la). 
Stimulation of CD6+ T cells with plate-bound anti-CD3 in 
the presence of IL-4 and anti-IFNy also induced the gener- 
ation of cells secreting IL-4 and IL-5, although some IFNy 
was also secreted by this population (Figure 1 b). Finally, 
Th2-like CD6+ T cells could also be generated in the pres- 
ence of IL-4 and anti-IFNy if allogeneic BALWc spleno- 
cytes were used as antigen-presenting cells (Figure lc), 
thus confirming that IL-4- and ILd-secreting CD6+ T cells 
could be generated with different stimulation conditions. 
To confirm that IL-4 and IL-5 were produced by the CD8+ 
cells and not by some other contaminant populations 
grown in the presence of IL-4, we sorted CD6a’CD6l3’ T 
cells after 6 days in IL-4 plus anti-IFNy (Figure 2a). The 
sorted CDBa+CDBP+ T cells produced similar amounts of 
IL-4, IL-5, IL-6, and IL-l 0 to the unsorted population, which 
was 76% CDBa+CD6/3+ (Figures 2a, 2b). 
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Figure 2. Sorted ILWAnti-IFNY-Derived CD8+ T Ceils Secrete a Th2- 
Like Cylokine Pattern 
Purified C57BU6 CD8’ Tceiiswere stimulated with aliogeneic Ml 2.4.1 
cells for 6 days under various growth conditions. On day 6, the cells 
were collected and an aliquot of the ceils generated in the presence 
of IL-2 plus IL-4 plus anti-IFNy were sorted for CD8 expression (a). 
Sorted and unsorted cells were then washed and stimulated with Con 
A for 24 hr. Cytokine levels were measured in the supernatants (b). 
The scales for each cytokine represent: U/ml x 10m2 (IL-2); U/ml x 
10.‘(IL-IO); nglmi(iL-4, IL-5); and ng/mi x IO-‘(IFNy, IL-6).Themeans 
and standard deviations of triplicate cultures are shown. 
CD8+ T Cell Clones Produce Either IL-2 and IFNy 
or IL-4, IL-5, and IL-10 
To confirm further that CD8+ T cells can secrete ThPlike 
cytokines, we carried out limiting dilution cloning with 
CD8+ T cells in cytokine combinations favoring either IL-21 
IFNy or IL-4/IL-5 differentiation. In different experiments, 
the distribution of wells with T cell growth corresponded 
to cloning frequencies ranging from 0.3%-l% of the input 
CD8’cells. Cultures chosen for further analysis had proba- 
bilities of 80%-97% of being derived from a single CD8+ 
cell, assuming a Poisson distribution. Putative clones de- 
rived in the presence of IL-4 plus anti-IFNy secreted IL-4, 
IL-5, and IL-10 but not IL-2 or IFNy, whereas the clones 
derived in the presence of IFNy plus anti-IL-4 secreted 
IL-2 and IFNy but not IL-4, IL-5, or IL-10 when restimulated 
(Figure 3). By analogy with the Thl and Th2 CD4+ T cell 
subsets, we propose that the IL9/lFNy- and IL+IL-5- 
secreting subsets be referred to as TCl and TC2 CD8’ T 
cells, respectively. Both the TCl and TC2 subsets pro- 
CD8+ T Cells Secreting Thl or Th2 Cytokines 
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Figure 3. CD8’ T Cell Clones Secrete Either IL-2 and IFNy or IL-4, 
IL-5, and IL-10 
CD8+ clones were generated by limiting dilution of purified C57BU6 
CD8+ T cells in the presence of irradiated TA3 cells under conditions 
favoring differentiation into TCl (IL-2 plus IFNy plus anti-IL-Y or TC2 
(IL-2 plus IL-4 plus anti-IFNr) cells. On day 6, each clone was stimu- 
lated with TA3 cells for another 6 days in the presence of the same 
cytokine combinations. On day 12, aliquots of each clone were stimu- 
lated with Con A for cytokine production. Dotted lines indicate the 
assay thresholds, except for TNF (threshold 0.1 pglml). 
duced similar levels of TNF, whereas TC2 but not TCl 
cells secreted low levels of IL-3. These results clearly indi- 
cate that CD8+ cells can differentiate into two distinct sub- 
sets, both CD8+, that secrete patterns of cytokines very 
similar to the Thl and Th2 patterns defined by CD4’ cells. 
TCl and Some TC2 CD8+ Clones Have Stable 
Cytokine Secretion Phenotypes 
To ascertain whether the TCl and TC2 cells were stable, 
we stimulated an aliquot of each limiting dilution clone 
with TA3 cells in the presence of either IFNy plus anti-IL-4 
or IL-4 plus anti-IFNy. After 6 days, the cells were washed 
and restimulated, and the cytokine profiles were tested. 
Established TCl cells continued to make IFNy but not IL-4 
or IL-5, even after two rounds of stimulation with antigen 
in the presence of IL-4 plus anti-IFNy (Figure 4). Similarly, 
TC2 cells continued to secrete IL-4 and IL-5 even if they 
were stimulated twice in the presence of IFNy plus anti-IL4 
However, some TC2 limiting dilution clones remained neg- 
ative for IFNy secretion, whereas others acquired the abil- 
ity to secrete IFNy. None of the clones showed a complete 
conversion from the TC2 to the TCl pattern. Thus, TCl 
IFNv IL-4 
- - 
rb 
Cytokine secretion (nglml) 
Figure 4. CD8’ TCI and Some TC2 Clones Express Stable Cytokine- 
Secreting Phenotypes 
Aliquots of the TCl and TC2 CD8’ T cell clones described in Figure 
3 were split on day 12 and restimulated in conditions favoring differenti- 
ation into TCI (IL-2 plus IFNy plus anti-IL+ or TC2 (IL-2 plus IL-4 plus 
anti-IFNy) cells. Each aliquot was restimulated on day 15. and on day 
18, cells were thoroughly washed and stimulated with Con A for 24 
hr. Cytokines were measured in the supernatants. 
and many TC2 CD8’ T cell clones have stable cytokine 
secretion phenotypes. 
Cell Surface Characteristics of TCl 
and TC2 CD8+ Cells 
Allospecific CD8+ TCl and TC2 lines were established, 
and after two cycles of stimulation, the cells were stained 
with antibodies against various cell surface markers. The 
two populations expressed similar surface markers: the 
great majority of the cells were CD4-, CD8a+, CDSp+, 
CD45+, CD44+, NKl .l- (Figures 5a, 5b). The expression 
of the two chains of CD8 is of particular interest, as CD8+ 
cells stimulated with ionomycin, PMA, and IL-4 lost the 
expression of CD8 while acquiring the ability to secrete 
IL-4 (Erard et al., 1993). The results in Figure 5 clearly 
indicate that TCl and TC2 CD8’ populations derived by 
allogeneic stimulation express similar levels of both a and 
6 chains of CD8. 
Neither TCl Nor TC2 CD8+ T Cells Provide Cognate 
Help for B Cells 
Allospecific CD4’ and CD6 TCl and TC2 T cell lines were 
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Figure 5. Both TCl and TC2 CD8+ Cells Show Similar Surface Antigen 
Expression 
TCl andTC2CD8+TcelllineswereestablishedasdescribedinExperi- 
mental Procedures and stained with anti-mouse CD4-PE, CD8a- 
FITC, CD88-PE, NK l.l-PE, CD45-FITC, and biotin rat anti-mouse 
CD44 Cells were analyzed by flow cytometry. Data from at least 25,000 
cells were collected. 
established by stimulating CBA/J (H-2k) spleen CD4+ or 
CD8+ T cells with irradiated TA3 cells (H-2k’d). These cells 
were then tested for the ability to help purified allogeneic 
BALBlc (H-2q B cells to secrete antibodies of various iso- 
types in the presence of IL-4. Both subsets of CD8’T cells 
failed to help B cells (Figure 8a), under conditions that 
revealed allo-helper activity from either CD4+ ThBlike cells 
(IgGl, lgG2a, IgGPb, and IgM), and CD4’ Thl-like ceils 
(IgGPa and IgM). In cultures containing the higher num- 
bers of CD8+ cells, the antibody levels were actually lower 
than in control cultures, possibly owing to killing of the B 
cells by the cytotoxic TCl and TC2 CD8+ cells (see below). 
Anti-CDB-Stimulated TC2 Cells Provide Help for B 
Cell Antibody Production 
Allospecific anti-H-2d TCl and TC2 lines were generated 
as described above. Potential helper activity was then 
tested in another B cell activation system in which BALBlc 
B cells and TCl or TC2 cells were cocultured with plate- 
bound antiCD3. Under these conditions, T cells should 
be activated on the plastic surface, rather than directly on 
the B cell surface. TC2 cells induced substantial levels of 
antibody production in these cultures (Figure 8b). 
Both TCl and TC2 CD8+ T Cells Are Cytotoxic 
Allospecific (anti-H-2d) TCl and TC2 CD8+ T cell lines were 
generated and evaluated for cytotoxicity against 51Cr la- 
beled P815 and EL4 cells at 2,3, and 4 days after the last 
alloantigen stimulation. Figures 7a, 7b, and 7c demon- 
strate that both TCl and TC2 cells were highly cytotoxic 
for P815 target cells. Syngeneic EL4 tumor cells were not 
killed by either TCl or TC2 CD8+ T cells. TC2 cells showed 
strong cytotoxicity (greater than 50% at 1:l E:T ratio), 
whereas TCl cells were less cytotoxic when cultured in 
IFNy plus anti-IL-Q. However, TCl cells restimulated for 
1 week in IL-12 showed increased cytotoxicity, at levels 
equivalent to TC2 cultures. Both TCl and TC2 CD8+ cells 
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Figure 8. Neither CD8+ TCl Nor TC2 Cells Provide Cognate Help for 
B Cell Antibody Production 
Allospecific anti-H-2d TCl or TC2 CD8’or CD4’T cell lines were estab- 
lished as described in Experimental Procedures. Allospecific effector 
T cells were irradiated (2,500 rads) and cocultured with BALB/c B cells 
(1 x 105 cells/well) in the presence of (a) IL-2 (50 U/ml) and IL-4 (1 ngl 
ml), or(b) plate-bound anti-CD3 antibody. Supernatants were collected 
after 7 days and immunoglobulin production was assayed by ELISA. 
Means f standard deviations of triplicate cultures are shown. 
killed with similar kinetics (data not shown) and both also 
killed allogeneic but not syngeneic Con A blasts, confirm- 
ing that killing was antigen specific (Figure 7d). 
To confirm the cytotoxic ability of both TCl and TC2 
cells, limiting dilution clones were isolated in either TC2 
(IL-2 plus IL-4 plus anti-IFNy) or TCl (IL-2 plus IL-12) condi- 
tions. IL-12 was used in this experiment because of the 
better growth (data not shown) and cytotoxicity (Figures 
7a, 7b, 7c) of TCl cells in the presence of IL-12. Five 
putative clones of each type were chosen, and had proba- 
bilities of 90%-95% of being derived from a single CD8+ 
cell, assuming a Poisson distribution. By FACS analysis 
(Figure 8a), all clones were CD4- CD8+, and the cytokine 
patterns (Figure 8b) showed the clearcut Thl- and TM-like 
patterns shown in previous figures. Both TCl and TC2 
limiting dilution clones showed strong cytotoxicity for 
M12.4.1 target cells, but not EL4 control cells (Figure 8~). 
Most of the putative clones killed more than 20% of the 
target cells at E:T ratios of 0.25 or less. 
Discussion 
Stimulation of CD8+ T cells in the presence of IL-2 leads 
to the generation of cells that secrete a Thl-like cytokine 
pattern when restimulated (Prystowsky et al., 1982; Kelso 
and Glasebrook, 1984; Fong and Mosmann, 1990). We 
C&8+ T Cells Secreting Thl or Th2 Cytokines 
Figure 7. Both TCl and TC2 CD8+ Cells Are Cytotoxic 
C57Bl16 spleen CD8+ T cells were stimulated with M12.4.1 cells in 
IL-2 only, or TCl (IL-2 plus IFNy plus anti-IL-4) or TC2 (IL-2 plus IL-4 
plus anti-IFNy) conditions for 7 days, restimulated in the presence of 
the same cytokines (and also IL-2 plus IL-12 for an aliquot of TCl 
cells) for another 7 days. The cells were then restimulated and tested 
for the ability to lyse allogeneic and syngeneic %r-labeled tumor and 
normal T cell targets after 2, 3, and 4 days (a, b, c). In another experi- 
ment, BALBlc and C57/BL6 Con A blasts were used as targets (d). 
Various ratios of effecters to targets were cocultured for 4 hr and the 
supernatants were collected and radioactivity detected by y counting. 
Means rt standard deviations of triplicates are shown. 
have now shown that IL-Q, especially in the presence of 
anti-IFNy, induces CD8+ T cells to develop into cells that 
secrete cytokines similar or identical to the Th2 pattern 
(IL-4, IL-5, IL-8 and IL-10 but not IL2or IFNy) when restim- 
ulated. This induction of ThP-like cells occurs whether 
CD8+ cells are stimulated with an allogeneic B cell 
lymphoma, allogeneic spleen cells, or immobilized anti- 
CD3 antibodies. Compared with CD4’ cells, CD8’ cells 
show a stronger bias towards differentiation into aTh1 -like 
state, as in our culture system, CD4’ T cells (Sad and 
Mosmann, 1994) spontaneously differentiate into IL-4- 
producing cells, whereas CD8’ cells require exogenous 
IL-4, anti-IFNy, or both. Even in the presence of the large 
amounts of IL-4 and anti-IFNy used in the current study, 
a minority of experiments showed low levels of IFNy pro- 
duction (e.g., Figure 1 b; data not shown). It is conceivable 
that, relative to CD4+ cells, naive CD8+ T cells are more 
susceptible to endogenous costimulators that promote 
TCl differentiation or less susceptible to TCP-promoting 
agents such as IL-4, or a combination of the two. This may 
explain why the TC2 CD8+ cells have not been readily 
observed in previous studies (Fong and Mosmann, 1990, 
T. A. T. Fong and T. Ft. M., unpublished data). 
The role of IFNy in enhancing differentiation towards 
Thl and TCl cells is not yet entirely clear. IFNy has been 
clearly implicated in Thl differentiation (Sad and Mos- 
mann, 1994; Macatoniaet al., 1993)and Figure lademon- 
strates IFNy is important for the differentiation of CD8’ T 
cells into TCl cells. However, this does not prove that 
IFNy is the onlyThl/TCl-inducing factor. Studies showing 
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Figure 8. TCl and TC2 Limiting Dilution Clones Are CD8+ and Cyto- 
toxic 
Limiting dilution clones ((X781/6 anti-M12.4.1) were isolated in TCl 
(IL-2 plus IL-12) and TC2 (IL-2 plus IL-4 plus anti-IFNy) conditions, 
stimulating with alloantigen every 3 days. At 15 days, aliquots of each 
limiting dilution clone were analyzed for surface antigen expression 
by FACS (a), and for cytokine production after stimulation with Con 
A for 24 hr (b). On day 18, cytotoxicity of a further aliquot was assayed 
on %r-labeled M12.4.1 and EL4 target cells (c). 
that IFNy has minimal effectson Thl differentiation (Seder 
et al., 1993) may suggest that there are multiple pathways 
that enhance Thl/TCl differentiation. This is supported 
by the studies of Seder et al. (1993) which also show that 
anti-IFNy antibodies inhibit the development of IFNy- 
secreting cells in the absence but not presence of acces- 
sory cells. An alternative explanation for the apparent lack 
of effect of anti-IFNy in some systems may be that high 
dosesof theanti-IFNyantibodyXMG1.2arerequired,such 
as 50 uglml, (Sad and Mosmann, 1994; Figure l), rather 
than 10 pg/ml (Seder et al., 1993). 
Although mouse TC2 CD8’ T cell clones have, to our 
knowledge, not previously been described, there have 
been reports of IL4-secreting CD8+ T cell populations. 
Purified CD8+ normal mouse T cells stimulated with anti- 
CD3 in the presence of IL-4 subsequently secreted IL-4, 
and may have been similar to the TC2 CD8’ cells identified 
in this study, although the expression of other Thl and Th2 
cytokines was not tested (Seder et al., 1992). However, in 
another study, a different type of IL-4-secreting T cell was 
derived by stimulation with ionomycin and PMA. These 
cells were initially CD8+, but after stimulation in the pres- 
ence of IL-4 they lost expression of CD8, secreted IL-4, 
IL-5, and IL-lo, helped B cells in the presence of immobi- 
lized antiCD3, and failed to lyse target cells (Erard et al., 
1993). Some of these properties are quite different from 
the allospecific TC2 CD8+ cells that we have described: 
we do not observe a loss of CD8 expression of either bulk 
populations or limiting dilution clones of TC2 cells; and 
they are highly cytotoxic. It is not yet clear whether the 
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ionomycin-derived CD8- cells have a normal counterpart 
among cells derived by more physiological conditions of 
antigen stimulation. 
Human allospecific IL-4-secreting CD8’ T cell clones 
have been isolated (Paliard et al., 1988). Cytotoxic TCl 
CD8+ T cell clones (secreting IFNy but not 11-4) were de- 
rived from healed lesions of patients with tuberculoid lep- 
rosy, whereas clones that secreted IFNy, IL4 IL-5, and 
IL-1 0 were derived from patients with lepromatous leprosy 
(Salgame et al., 1991). The IL-Cproducing CD8+ clones 
suppressed the antigen-specific proliferation of M. leprae- 
specific CD4+ T ceil clones by a mechanism involving se- 
cretion of IL-4. Although the latter study referred to the 
IL-Cproducing clones as type 2, the majority of both the 
allospecific (Paliard et al., 1988) and M. leprae-specific 
(Salgame et al., 1991) clones might be described instead 
as type 0, because they produced both IL-4 and IFNY. 
Human CD8+ and CD8- T cell clones secreting a more 
typical TC2 pattern (IL4 and IL-5 but not IFNy) were de- 
rived by phytohemagglutinin stimulation from peripheral 
blood lymphocytes and skin biopsies of HIV-infected indi- 
viduals with Jobs-like syndrome but not from normal indi- 
viduals(Maggi et al., 1994). Thus, both human and mouse 
TC2 CD8+ T cell clones have so far only been described 
under conditionsof astrongly perturbed immune response 
in vivo (Maggi et al., 1994) or in vitro (Figure 3). 
Both the TCl and TC2 mouse CD8+ T cells, like their 
CD4+ counterparts, appear to be stable phenotypes. We 
have not been able to interconvert the two types after their 
commitment, although some of the TC2 CD8+ clones ac- 
quired a ThO-like pattern of cytokine synthesis on ex- 
tended culture. If initial differentiation into TC2 cells oc- 
curred after commencement of clonal proliferation, it is 
possible that a minority of cells within a generally TC2 
clone remained uncommitted, and could subsequently 
give rise to TCl CD8+ T cells. This would explain why 
some but not all TC2 clones acquired the ability to secrete 
IFNy. Alternatively, the acquisition of IFNy-secreting abili- 
ties by some TC2 clones may be related to the general 
tendency of CD8+ cells to express IFN?. Although IL-4 or 
IFNr did not cause interconversion of the two phenotypes, 
some cross-enhancing effects on the differentiated cells 
were observed. IL-4 enhanced the cytokine synthesis or 
proliferation (Figure 4) of TCl clones. Conversely, TCl 
growth conditions sometimes enhanced proliferation or 
cytokine synthesis of TC2 clones (Figure 4). 
The similarity of the CD8+ TCl and TC2 clones and bulk 
populations to their CD4’ counterparts extends beyond 
the synthesis of IL-4 and IFNy: for all six of the Thl- or 
ThPspecific cytokines tested, TCl and TC2 CD8+ cells 
showed the Thl and Th2 patterns of cytokine expression, 
respectively. The only exception identifed so far to this 
concordance between CD4+ and CD8+ cells is the expres- 
sion of low levels of the Thl/Th2 common cytokine IL-3 
by TC2 cells, and undetectable levels by TCl cells. 
The cytotoxicity of CD8’ cells is enhanced by IL-4 in a 
number of experimental systems. IL-4 increases the cyto- 
toxicity of CD8’ T cells stimulated with alloantigen 
(Widmer and Grabstein, 1987), lectin (Pfeifer et al., 1987), 
or viral antigen (Horohov et al., 1988). IL-4 also synergizes 
with phorbol esters or with monoclonal anti-T cell receptor 
antibody to stimulate the development of cytotoxic T lym- 
phocyte (CTL) from small resting mouse T cells (Trenn et 
al., 1988). In some systems, IL-4 may be necessary for CTL 
generation, as anti-IL-4 antibodysubstantiallyinhibited the 
development of precursors into influenza virus-specific 
CTL clones in microcultures (Horohov et al., 1988). As 
cytokine levels were not measured in these studies, it is 
not clear in retrospect whether IL4 was enhancing cyto- 
toxicity of TCl- or TC2-like CD8+ cells. The cytotoxicity- 
enhancing effect of IL-4 appears to occur before the actual 
killing reaction, as neither IL-4 nor anti-IL-4 alter the cyto- 
toxicity of TCl or TC2 cells when added during the cytotox- 
icity assay (data not shown). Thus, IL-4 induces prolifera- 
tionof CDB+Tcells(Widmer andGrabstein, 1987; Horohov 
et al., 1988) drives their differentiation to highly cytotoxic 
TC2 CD8+ cells (Figure 7) and, in addition, possibly en- 
hances the cytotoxic ability of TCl CD8+ cells, TC2 CD8+ 
cells, or both. 
Although CD8+ TC2 cells secrete a very similar cytokine 
pattern to CD4+ Th2 cells, their functions appear to be 
more similar to CD8’TCl cells than Th2 cells. Both CD8+ 
subsets are cytotoxic, and both probably recognize major 
histocompatibility complex class I, as they effectively kill 
allogeneic T cell blasts that lack major histocompatibility 
complex class II. In contrast with the CD4+ T cell subsets, 
CD8+TcellsofeithertheTCl orTC2subset do not provide 
cognate help for B cells. However, allospecific TC2 cells 
could provide B cell help if the T cells were triggered by 
solid-phase anti-CD3 antibodies rather than directly on the 
B cell surface (Figure 8b). Similar anti-CD3-mediated help 
was demonstrated for IL-4-producing human cytotoxic 
(Maggi et al., 1994) or mouse non-cytotoxic (Erard et al., 
1993) CDB-derived T cells. 
The lackof allospecific cognate help in our studies might 
be because any potential help of CD8+ TCl and TC2 cells 
is nullified by their cytolytic capacity, either directly or via 
the production of soluble cytokines. This cytolytic activity 
might not kill B cells in the anti-CD3 system because the 
directional killing mechanism(s) may be oriented towards 
the anti-CD3-coated plate instead of the B cells. Bystander 
help might then be mediated by soluble TC2 cytokines, 
or more likely, by TC2 cytokines in conjunction with cell 
surface-mediated activation signals such as CD40 ligand 
(Armitage et. al., 1992). 
When considering the potential role of TC2 cells during 
a physiological antibody response, it is also difficult to 
reconcile cognate CD8’ B cell helper activity with the cur- 
rently known antigen-processing pathways. If the TC2 
CD8+ cells recognize antigen in association with major 
histocompatibility complex class I, they would probably 
not be able to respond to antigen processed as a result 
of antibody capture by a specific B cell (Lanzavecchia, 
1990). It is still possible that the cytokines secreted by 
TC2 CD8’ T cells may provide bystander help for B cells 
activated by cognate interaction with CD4+ helper T cells. 
While the existence and physiological significance of 
the TC2 CD8+ T cells in vivo awaits further analysis, one 
can speculate that such cells might act as regulatory cells 
that check exacerbated immune responses. As IL4- 
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producing cells from individuals with lepromatous leprosy 
suppress proliferation of CD4+ T cells, TC2 cells secreting 
ThP-like cytokines may inhibit the proliferation of CD4+ 
Thl cells but still kill target cells loaded with antigen. In 
contrast with TCl CD8+ cells, which secrete a cytokine 
pattern that inhibits Th2 (antibody) responses, the TC2 
CD8+ cells may thus be important for allowing the coexis- 
tence of strong cytotoxic and antibody responses. 
Experimental Procedures 
Mice 
Female BALB/c mice, 4-6 weeks old were obtained from Health Sci- 
ences Laboratory Animal Services, University of Alberta, Ellerslie, Al- 
berta, Canada. Female C57BU6 and CBA/J mice, 4-6 weeks old were 
obtained from the Jackson Laboratories, Bar Harbor, Maine. Micewere 
maintained in Health Sciences Laboratory Animal Services (Edmon- 
ton, Alberta, Canada) in accordance with the guidelines of the Cana- 
dian Council on Animal Care. 
Cell Lines 
The mouse hybrid B cell line TA3 (Glimcher et al., 1963) expressing 
H-2dn was obtained from Dr. B. Singh, and the parental B lymphoma 
cell line M12.4.1 (Glimcher et al., 1963) expressing H-2d was obtained 
from Dr. L. Glimcher. 
Cytoklnes and Antfbodles 
Mouse recombinant IL-2 was expressed in Escherichia coli (Zurawski 
et al., 1966) and used as a partially purified preparation at 500 U/ml. 
Recombinant mouse IL-4, 11-12, and IFNy were expressed in COS 
cells (Lee et al., 1966) and used as a dilution of COS transfection 
supernatants. Anti-IFNy and anti-IL-4 antibodies were purified on a 
protein G column from the supernatants of XMGl.2 (Cherwinski et al., 
1967)and llBl1 (Oharaand Paul, 1965)celllines.ConAwasobtained 
from Pharmacia, Uppsala, Sweden. Biotinylated anti-mouse Pgpl 
(CD44, clone IM7), Ly3-PE (anti-CD65 clone 535.6) B220-fluores- 
cein isothiocyanate (FITC) (clone RA3-6B2), CD45-FITC (clone 
3OFll.l) and NK-l.l-(phycoerythrin) PE (clone PK136) were ob- 
tained from PharMingen (San Diego, California). Streptavidin-FITC 
was obtained from Southern Biotechnology Associates, Incorporated 
(Birmingham, Alabama). Rat anti-mouse LyP-FITC (anti-CDBa, clone 
MS 169.4) and L3T4-PE (clone YTS 191.1) were obtained from Ce- 
darlane Laboratories Limited, Hornby, Ontario, Canada. Fetal bovine 
serum (FBS) was obtained from Hyclone Labs, Logan, Utah. 
Cell Cultures 
C57BU6 CD6’ T cells were enriched by removal of 6 cells, CD4’ T 
cells, and macrophages on rat T columns (Biotex, Edmonton, Alberta, 
Canada). Splenocytes (150 x 10’) were incubated with a rat anti- 
mouse CD4 antibody (clone YTS 191 .l) and loaded onto glass bead 
columns coated with sheep anti-rat immunoglobulin (cross-reactive 
with mouse immunoglobulin). Cells that passed through the column 
were 60%-90% CD6+ as analyzed on a FACScan (Becton Dickinson, 
Mountain View, California). In some experiments, CD6+ T cells were 
further purified by sorting on a Coulter EPICS Elite cell sorter (Coulter 
Electronics, Hialeah, Florida) after staining the cells with rat anti- 
mouse Ly2-FITC (clone MS 169.4). CD6’ T cells (5 x 10”lwell) were 
stimulated with 5 x 10’ irradiated TA3 or M12.4.1 cells (10,000 rads) 
or with 1 x 1 O8 irradiated BALB/c spleen cells (2,500 rads) in a 96well 
tissue culture plate in 200 ul RPM1 plus 6% FBS in the presence of 
various cytokines. IL-2 was added at 500 U/ml and, where appropriate, 
IFNy was added at 5 @ml, anti-IFNT (XMG1.2) at 50 @ml, anti-IL-4 
(11 Bl 1) at 25 pglml, and IL-4 at 25 nglml unless otherwise mentioned. 
Media (100 ul) were replaced 3 days later, and on day 5 the cells 
were washed and restimulated (5 x 10e/ml) with Con A (5 @g/ml). 
Supernatants were collected after 24 hr for cytokine estimation by 
enzyme-linked immunosorbent assay (ELISA). 
C57BU6 CD6’ T cells were also stimulated with plate-bound anti- 
CD3 (145-2C11, Bluestone et al., 1967). In brief, 96-well plates were 
coated with the anti-CD3 antibody (20 &ml) for 1 hr. After thorough 
washing of the plates with PBS, CD6+ T cells (1 x 1 O’lwell) and synge- 
neic irradiated (2500 rads) C57BU6 spleen ceils (1 x lO?well) were 
plated onto each well in RPM1 1640 plus 6% FBS. On day 3, 100 PI 
media were replaced and cells restimulated on day 5 with Con A 
(5 kg/ml). Supernatants were collected after 24 hr for cytokine estima- 
tion by ELISA. 
Generation and Dlfferentlatlon of Long-Term T Cell Lines 
and Clones 
C57BU6 CD6’ T cells were cloned by limiting dilution in the presence 
of cytokine combinations favoring differentiation into TCI (IL-2 plus 
IFNy plus anti-IL-4 or IL-2 plus IL-12) or TC2 (IL-2 plus IL-4 plus anti- 
IFNy) phenotypes. Concentrations of cytokines and antibodies were 
as previously mentioned. Limiting dilution cloning was carried out by 
stimulating the C57BU6 CD6’ T cells (1000 cells/well to 0.5 cells/ 
well) with irradiated TA3 or M12.4.1 cells (5 x lO’/well) in swell 
round-bottomed tissue culture plates in 200 ul RPM plus 6% FBS. 
Every third day, 100 cl of media were replaced. 
BulkCD6’TCl andTC2Tcelllineswerealsogenerated bystimulat- 
ing C57BU6CD6+Tcells(5 x lO?well)with irradiatedTA3 or M12.4.1 
cells (5 x 10’lwell) in the presence of cytokine combinations favoring 
differentiation into TCI (IL-2 plus IFNy plus anti-IL4, or IL-2 plus 11-12) 
orTC2(IL-2plus IL4plusantMFNy) phenotypes. Cultureswerediluted 
as necessary and stimulated with irradiated TA3or M12.4.1 cellsevery 
third day in the presence of the same cytokines. After 12-14 days, 
these bulk cultures were used to test the cytotoxicity and surface anti- 
gen expression of the TCI and TC2 T cells. 
B Cell Help 
CBA (H-2k) CD6+ or CD4’ T cells (5 x lO’/well) were stimulated with 
irradiated TA3 cells (5 x lO’/well, H-2m) in the presence of cytokines 
favoring differentiation into Thl- or ThP-like phenotypes as described 
above. To evaluate allospecific cognate help, on day 12, the resulting 
effector T cells were irradiated (2500 rads) and cocultured with H-2d 
B cells (1 x 10” cells/well) for 7 days. To purify B cells, BALB/c spleno- 
cytes were plated on plastic petri dishes for 30 min at 37OC. Nonadher- 
ent cells were collected and stained with rat anti-mouse CD4-PE, 
CDB-PE, and B220-FITC on ice for 30 min in RPM1 plus 1% FBS. 
8220’ CD4- CD6- cells were then sorted on a Coulter EPICS Elite 
cell sorter (Coulter Electronics, Hialeah, Florida) and cocultured with 
irradiated T cells. To evaluate help by anti-CD3-stimulated TC cells, 
allospecific (anti-H-p) effector T cells were cocultured with purified 
BALBlc B cells on 96well round-bottomed trays previously coated with 
20 ug/ml anti-CD3 antibodies. The supernatants were collected 7 days 
later and immunoglobulin levels were assayed by ELISA. 
Cytoklne and lmmunoglobulln lsotype Assays 
Cytokines produced in the supernatants were assayed by ELISA (Mos- 
mann and Fong, 1969). The following antibodies were used: R4-6A2 
(American Type Culture Collection; ATCC HBI 70) and XMGl.2-biotin 
for 1FN-r; BVDCI Di 1 and BVD6-24G2-biotin (PharMingen) for 11-4; 
TRFK5 and TRFK4-biotin (PharMingen) for IL-5; JES61A12 and 
JES&5H4-biotin (PharMingen)for 11-2; 6FBand 43Dll-biotin (Yokota 
et al., 1966) for 11-3; and SXCP and SXCl-biotin (Mosmann et al., 
1990) for IL-lo. TNF was assayed on WEHI-164.13 cells essentially 
as described (Espevik and Nissen-Meyer, 1986) except that the assay 
was carried out in the presence of saturating (5 nglml) amounts of 
IFNy. lmmunoglobulin isotypes were assayed by ELISA using a mouse 
monoclonal antibody isotyping reagent kit (ISO-2, Sigma Chemical 
Company, St. Louis, Missouri) according to the instructions of the 
manufacturers. 
Cytotoxlclty Assays 
TCI and TC2 T cell lines were generated as described above and 
used as effector cells after 12-14 days of culture. Tumor cell lines 
(P615, EL4, and M12.4.1) or BALBlc and C57/BL6 Con A blasts were 
used as targets. The Con A blasts were derived by stimulating spleen 
cells (4 x l@/ml) with Con A (2 &ml) in RPM1 plus 6% FBS for 
3 days. Df 51Cr, 100 uCi was used to label 10’ taraet cells in 60 ul 
medium. Target cells were washed, and various ratios of effecters to 
targets were cocultured for 4 hr, and the supernatants were collected 
and radioactivity was detected by y counting. The percent cytotoxicity 
was calculated using the formula: 
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(cpm experimental - cpm spontaneous) I (cpm total - 
cpm spontaneous). 
FACS Anslysis 
For CD4 and CD8 staining, T cells were washed and incubated on 
ice (1 x 10 cells in 50 pl RPM plus 1% FBS) with rat anti-mouse CD4- 
PE and rat anti-mouse CDBa-FITC. Cells were thoroughly washed 30 
minutes later, fixed in 1% formaldehyde in PBS, and analyzed on a 
FACScan. Data from at least 25,000 cells were collected. Cells were 
also stained with antiCDBl+PE, NK 1.1-PE, CD45-FITC. and biotin 
rat anti-mouse CD44. Biotinylated antibody was detected by adding 
streptavidin-FITC to the cells after thorough washing. Cells were 
treated and analyzed as mentioned above. 
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